Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 2015

View Archived Issues

Novartis recaps progress of fourth quarter 2014

iCura in-licenses dry AMD program

Combination therapy of repurposed drugs shows promise for Charcot-Marie-Tooth disease

Novel treatment for cocaine addiction TV-1380 safe in healthy subjects

Lisdexamfetamine shows efficacy for treatment of BE disorder

Novavax presents update on development pipeline

Envisia Therapeutics begins phase IIa trial of ENV-515 in patients with glaucoma

CymaBay Therapeutics reports preclinical data for MBX-8025

BrainStorm reports preclinical data for NurOwn in mouse autism model

AgeneBio receives grant to support AGB-101 trial in amnestic mild cognitive impairment

enGene raises funds to develop intestinal gene delivery platform

Meda to transfer Onsolis North American marketing authorizations to BioDelivery Sciences

Advaxis reports update on phase II study of ADXS-HPV

Bayer patents novel Mnk1 inhibitors

GSK reports new EZH2 inhibitors

Ono Pharmaceutical discloses novel lipoxin receptor agonists

Applied Molecular Transport and Janssen establish IBD collaboration

New tyrosine kinase modulators designed at Zhejiang Beta Pharma

Investigators in Spain patent new PPAR agonists

PsychoGenics achieves milestone in Sunovion collaboration

Spark project launched to develop IPR-019 for schizophrenia-associated cognitive impairment

ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes

RegeneRx and G-treeBNT partner to develop RGN-259 in the U.S. for ophthalmic indications

AnaMar announces strategic realignment

Bill & Melinda Gates Foundation pledges commitment to Gavi

European Commission clears GSK's proposed transaction with Novartis

Biogen Idec, Fondazione Telethon and Ospedale San Raffaele collaborate on hemophilia gene therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...